BRCA2 and breast carcinoma: The array comparative genomic hybridisation (aCGH) BRCA1-like and BRCA2-like classifiers are two HRD-tests that have been developed from the characteristic DNA copy number aberrations of BRCA1- and BRCA2-mutated breast cancers, respectively [26, 27].